Your shopping cart is currently empty

Rifalazil (KRM-1648) is a benzophenazine antibiotic with antibacterial activity. It inhibits bacterial RNA polymerase, blocking the β-subunit, and is used in Chlamydia infection research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $99 | - | In Stock |
| Description | Rifalazil (KRM-1648) is a benzophenazine antibiotic with antibacterial activity. It inhibits bacterial RNA polymerase, blocking the β-subunit, and is used in Chlamydia infection research. |
| In vitro | The MIC50 values of Rifalazil were 0.0015, 0.0039 and 0.0313 μg/ml for Clostridium difficile, Clostridium perfringens and Bacteroides fragile, respectively. Rifalazi showed antibacterial activity against gram-negative gut bacteria with MIC50 values of 16 μg/ml for Escherichia coli and 16 ug/ml for Klebsiella pneumoniae. [1] The MIC of Rifalazil against rifampicin-resistant mutants of Chlamydia pneumoniae was 0.125 μg/ml. [4] |
| In vivo | Treatment with Rifalazil (5 or 10 mg/kg orally for 15 weeks) improved the redness and swelling of the foot pads in mice with ulcer-infected models. [2] Rifalazil (20 mg/kg for 5 days) can treat and prevent recurrence of Clostridium difficile-associated diarrhea in hamsters. [3] |
| Synonyms | KRM-1648, KRM1648, ABI-1648, ABI1648 |
| Molecular Weight | 941.07 |
| Formula | C51H64N4O13 |
| Cas No. | 129791-92-0 |
| Smiles | C[C@H]1/C=C/C=C(C)\C(NC2=C3C(N=C4C(O3)=CC(N5CCN(CC(C)C)CC5)=CC4=O)=C6C(C2=O)=C(O)C(C)=C7C6=C(O)[C@](O/C=C/[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@H]1O)(C)O7)=O |
| Relative Density. | 1.31g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| Solubility Information | DMSO: 4 mg/mL (4.25 mM), Sonication is recommended. | ||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (1.06 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
| |||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.